발기부전 치료제 시장 규모는 향후 수년간 약간의 성장이 전망됩니다. 2029년에는 CAGR 1.6%로 44억 4,000만 달러로 성장합니다. 예측 기간의 성장은 정신건강 통합에 대한 집중, 소비자 선호도 변화, 신흥 국가 시장 확대, 재생 의학의 탐구, 바이오의약품의 혁신에 기인합니다. 예측 기간의 주요 동향으로는 새로운 치료법 개발, 인식 및 교육 향상, 라이프스타일의 변화와 건강 의식, 원격의료 및 온라인 상담, 혁신적인 전달 시스템 등이 있습니다.
만성질환의 상당한 증가는 발기부전 치료제 시장의 주요 촉진요인입니다. 발기부전은 주로 심혈관 질환, 당뇨병, 비만, 고혈압 등 앉아서 생활하는 생활습관으로 인한 만성질환과 관련이 있으며, 2023년 9월 세계보건기구(WHO)가 보고한 바와 같이 만성질환은 매년 4,100만 명의 사망을 유발하며, 전 세계 사망자의 74%를 차지합니다. 만성질환의 확산은 남성의 발기부전 가능성을 높이고, 그 결과 발기부전 치료제 시장을 촉진하고 있습니다.
고혈압 유병률 증가는 당분간 발기부전 치료제 시장의 성장을 가속할 것으로 예상됩니다. 고혈압은 동맥벽에 대한 지속적인 고혈압을 특징으로 하며, 널리 퍼져 있는 질환입니다. 실데나필과 같은 발기부전 치료제는 혈관 기능을 개선하고 혈압을 낮추며 혈류를 촉진하여 심혈관 건강을 증진시킴으로써 고혈압 관리에 기여하고 있습니다. 예를 들어 세계보건기구(WHO)는 2023년 3월 전 세계 30-79세 성인 중 약 12억 8천만 명이 고혈압을 앓고 있으며, 그 중 3분의 2가 중저소득 국가에 거주하고 있다고 보고했습니다. 따라서 고혈압 유병률 증가는 발기부전 치료제 시장의 성장을 가속하는 요인으로 작용하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, Covid, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 발기부전 치료제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
- 최종 용도 산업의 분석
- 세계의 발기부전 치료제 시장 : 성장률 분석
- 세계의 발기부전 치료제 시장 실적 : 규모와 성장, 2019-2024
- 세계의 발기부전 치료제 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계의 발기부전 치료제 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 발기부전 치료제 시장 : 약물별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Sildenafil Citrate
- Mirodenafil
- Vardenafil
- 세계의 발기부전 치료제 시장 : 투여 방법별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 경구
- 국소
- 주사
- 세계의 발기부전 치료제 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 발기부전 치료제 시장, Sildenafil Citrate의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 브랜드명(비아그라)
- 범용 폼
- 제형(정제, 츄어블)
- 세계의 발기부전 치료제 시장, Mirodenafil의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 브랜드명(Mvix)
- 제형
- 복합 제품
- 세계의 발기부전 치료제 시장, Vardenafil의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 브랜드명(Levitra, Staxyn)
- 제형
- 투여 경로(경구, 용해성)
제7장 지역별·국가별 분석
- 세계의 발기부전 치료제 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 발기부전 치료제 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 발기부전 치료제 시장 : 경쟁 구도
- 발기부전 치료제 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
- Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- Futura Medical plc
- Zydus Cadila
- Lupin Limited
- Cipla Limited
- Dong-A Pharmaceutical Co.
- Ltd.
- Aurobindo Pharma Ltd.
- Alembic Pharmaceuticals Ltd.
- Lupin Limited
- Glenmark Pharmaceuticals Ltd.
- Sun Pharmaceutical Industries Ltd.
- AvKARE Inc.
- Endo Pharmaceuticals Inc.
- Teva Pharmaceutical USA
- Aurobindo Pharma USA
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 발기부전 치료제 시장 2029 : 새로운 기회를 제공하는 국가
- 발기부전 치료제 시장 2029 : 새로운 기회를 제공하는 부문
- 발기부전 치료제 시장 2029 : 성장 전략
제36장 부록
KSA
Erectile dysfunction (ED) drugs are medications utilized to enhance the effects of nitric oxide, a naturally occurring substance in the body that relaxes penile muscles, aiming to address erectile dysfunction, which is the inability to achieve or maintain a penile erection in men.
Various types of ED drugs include sildenafil citrate, mirodenafil, and vardenafil. Sildenafil, available under trade names such as Viagra, is used to treat erectile dysfunction and pulmonary arterial hypertension. Its effectiveness in treating female genital dysfunction remains uncertain. These drugs can be administered orally, topically, or via injections, and are commonly distributed through hospital pharmacies, retail pharmacies, and online platforms.
The drugs for erectile dysfunction market research report is one of a series of new reports from The Business Research Company that provides drugs for erectile dysfunction market statistics, including drugs for erectile dysfunction industry global market size, regional shares, competitors with drugs for erectile dysfunction market share, detailed drugs for erectile dysfunction market segments, market trends and opportunities, and any further data you may need to thrive in the drugs for erectile dysfunction industry. This drugs for erectile dysfunction market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The drugs for erectile dysfunction market size has grown marginally in recent years. It will grow from $4.13 billion in 2024 to $4.16 billion in 2025 at a compound annual growth rate (CAGR) of 0.8%. The growth in the historic period can be attributed to introduction of pde5 inhibitors, pharmaceutical marketing and advertising, changing societal attitudes, rise in lifestyle-induced ed cases, generic medication availability.
The drugs for erectile dysfunction market size is expected to see marginal growth in the next few years. It will grow to $4.44 billion in 2029 at a compound annual growth rate (CAGR) of 1.6%. The growth in the forecast period can be attributed to focus on mental health integration, shift in consumer preferences, market expansion in emerging economies, regenerative medicine exploration, biopharmaceutical innovations. Major trends in the forecast period include development of novel therapies, increasing awareness and education, lifestyle changes and health awareness, telemedicine and online consultations, innovative delivery systems.
The significant rise in the number of chronic diseases is a key driver for the erectile dysfunction drug market. Erectile dysfunction is primarily linked to chronic conditions resulting from a sedentary lifestyle, such as cardiovascular diseases, diabetes, obesity, and high blood pressure. As reported by the World Health Organization (WHO) in September 2023, chronic diseases are responsible for 41 million deaths annually, accounting for 74% of all global deaths. The prevalence of chronic diseases heightens the likelihood of erectile dysfunction among men, consequently propelling the market for erectile dysfunction drugs.
The increasing prevalence of hypertension is anticipated to fuel the growth of the drugs for erectile dysfunction market in the foreseeable future. Hypertension, characterized by sustained high blood pressure against the artery walls, is a prevalent medical condition. Erectile dysfunction drugs, such as sildenafil, contribute to managing hypertension by improving blood vessel function, lowering blood pressure, and promoting overall cardiovascular health through enhanced blood flow. For instance, the World Health Organization (WHO) reported in March 2023 that an estimated 1.28 billion adults aged 30-79 years worldwide have hypertension, with two-thirds residing in low- and middle-income countries. Hence, the escalating prevalence of hypertension is a driving factor in the growth of the drugs for erectile dysfunction market.
Several companies in the erectile dysfunction drugs market are implementing new drug delivery techniques, such as pellets and creams. These innovations offer increased efficacy, performance, and safety in treating erectile dysfunction. For example, in September 2022, Lupin, an India-based pharmaceutical company, launched Sildenafil for oral suspension, 10 mg/mL, approved by the United States Food and Drug Administration (FDA). This drug delivery method provides unique dosages for treating erectile dysfunction, enhancing treatment options and potentially addressing concerns related to side effects.
Major players in the drugs for erectile dysfunction market are strategically focusing on introducing combination capsules, such as therapy capsules, to optimize revenue. Tamsulosin and Tadalafil, a combination of medications targeting benign prostatic hyperplasia (BPH) and erectile dysfunction, is gaining prominence. In September 2023, Akums Drugs & Pharmaceuticals Ltd., an India-based pharmaceutical company, launched a therapy capsule addressing both conditions in the Indian market. This capsule, containing a combination of Tamsulosin and Tadalafil, demonstrates significant improvements in BPH and the Erectile Dysfunction Index. The introduction of such therapy capsules provides a novel treatment option for patients grappling with both conditions, catering to a broader spectrum of needs in the market.
Major companies operating in the drugs for erectile dysfunction market include Pfizer Inc., Eli Lilly and Company, Bayer AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Futura Medical plc, Zydus Cadila, Lupin Limited, Cipla Limited, Dong-A Pharmaceutical Co., Ltd., Aurobindo Pharma Ltd., Alembic Pharmaceuticals Ltd., Lupin Limited, Glenmark Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., AvKARE Inc., Endo Pharmaceuticals Inc., Teva Pharmaceutical USA, Aurobindo Pharma USA, Hims & Hers Health Inc., Antares Pharma Inc., Acrux Limited, Mankind Pharma Ltd., Futura Medical plc, Adamis Pharmaceuticals Corporation
North America was the largest region in the drugs for erectile dysfunction market in 2024. Middle East is expected to be the fastest-growing region in the global drugs for erectile dysfunction market during the forecast period. The regions covered in the drugs for erectile dysfunction market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the drugs for erectile dysfunction market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The erectile dysfunction (ED) drugs market consists of sales Sildenafil (Viagra), vardenafil (Levitra, Staxyn), tadalafil (Cialis) and avanafil (Stendra). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Drugs For Erectile Dysfunction Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on drugs for erectile dysfunction market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for drugs for erectile dysfunction ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drugs for erectile dysfunction market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drugs: Sildenafil Citrate; Mirodenafil; Vardenafil
- 2) By Mode Of Administration: Oral; Topical; Injections
- 3) By End Users: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- Subsegments:
- 1) By Sildenafil Citrate: Brand Names (Viagra); Generic Forms; Dosage Forms (Tablets, Chewables)
- 2) By Mirodenafil: Brand Names (Mvix); Dosage Forms; Combination Products
- 3) By Vardenafil: Brand Names (Levitra, Staxyn); Dosage Forms; Administration Routes (Oral, Dissolvable)
- Companies Mentioned: Pfizer Inc.; Eli Lilly and Company; Bayer AG; Viatris Inc.; Teva Pharmaceutical Industries Ltd.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Drugs For Erectile Dysfunction Market Characteristics
3. Drugs For Erectile Dysfunction Market Trends And Strategies
4. Drugs For Erectile Dysfunction Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Drugs For Erectile Dysfunction Growth Analysis And Strategic Analysis Framework
- 5.1. Global Drugs For Erectile Dysfunction PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Drugs For Erectile Dysfunction Market Growth Rate Analysis
- 5.4. Global Drugs For Erectile Dysfunction Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Drugs For Erectile Dysfunction Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Drugs For Erectile Dysfunction Total Addressable Market (TAM)
6. Drugs For Erectile Dysfunction Market Segmentation
- 6.1. Global Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sildenafil Citrate
- Mirodenafil
- Vardenafil
- 6.2. Global Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Topical
- Injections
- 6.3. Global Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.4. Global Drugs For Erectile Dysfunction Market, Sub-Segmentation Of Sildenafil Citrate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Brand Names (Viagra)
- Generic Forms
- Dosage Forms (Tablets, Chewables)
- 6.5. Global Drugs For Erectile Dysfunction Market, Sub-Segmentation Of Mirodenafil, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Brand Names (Mvix)
- Dosage Forms
- Combination Products
- 6.6. Global Drugs For Erectile Dysfunction Market, Sub-Segmentation Of Vardenafil, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Brand Names (Levitra, Staxyn)
- Dosage Forms
- Administration Routes (Oral, Dissolvable)
7. Drugs For Erectile Dysfunction Market Regional And Country Analysis
- 7.1. Global Drugs For Erectile Dysfunction Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Drugs For Erectile Dysfunction Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Drugs For Erectile Dysfunction Market
- 8.1. Asia-Pacific Drugs For Erectile Dysfunction Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Drugs For Erectile Dysfunction Market
- 9.1. China Drugs For Erectile Dysfunction Market Overview
- 9.2. China Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Drugs For Erectile Dysfunction Market
- 10.1. India Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Drugs For Erectile Dysfunction Market
- 11.1. Japan Drugs For Erectile Dysfunction Market Overview
- 11.2. Japan Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Drugs For Erectile Dysfunction Market
- 12.1. Australia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Drugs For Erectile Dysfunction Market
- 13.1. Indonesia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Drugs For Erectile Dysfunction Market
- 14.1. South Korea Drugs For Erectile Dysfunction Market Overview
- 14.2. South Korea Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Drugs For Erectile Dysfunction Market
- 15.1. Western Europe Drugs For Erectile Dysfunction Market Overview
- 15.2. Western Europe Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Drugs For Erectile Dysfunction Market
- 16.1. UK Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Drugs For Erectile Dysfunction Market
- 17.1. Germany Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Drugs For Erectile Dysfunction Market
- 18.1. France Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Drugs For Erectile Dysfunction Market
- 19.1. Italy Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Drugs For Erectile Dysfunction Market
- 20.1. Spain Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Drugs For Erectile Dysfunction Market
- 21.1. Eastern Europe Drugs For Erectile Dysfunction Market Overview
- 21.2. Eastern Europe Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Drugs For Erectile Dysfunction Market
- 22.1. Russia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Drugs For Erectile Dysfunction Market
- 23.1. North America Drugs For Erectile Dysfunction Market Overview
- 23.2. North America Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Drugs For Erectile Dysfunction Market
- 24.1. USA Drugs For Erectile Dysfunction Market Overview
- 24.2. USA Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Drugs For Erectile Dysfunction Market
- 25.1. Canada Drugs For Erectile Dysfunction Market Overview
- 25.2. Canada Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Drugs For Erectile Dysfunction Market
- 26.1. South America Drugs For Erectile Dysfunction Market Overview
- 26.2. South America Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Drugs For Erectile Dysfunction Market
- 27.1. Brazil Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Drugs For Erectile Dysfunction Market
- 28.1. Middle East Drugs For Erectile Dysfunction Market Overview
- 28.2. Middle East Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Drugs For Erectile Dysfunction Market
- 29.1. Africa Drugs For Erectile Dysfunction Market Overview
- 29.2. Africa Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Drugs For Erectile Dysfunction Market Competitive Landscape And Company Profiles
- 30.1. Drugs For Erectile Dysfunction Market Competitive Landscape
- 30.2. Drugs For Erectile Dysfunction Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
31. Drugs For Erectile Dysfunction Market Other Major And Innovative Companies
- 31.1. Futura Medical plc
- 31.2. Zydus Cadila
- 31.3. Lupin Limited
- 31.4. Cipla Limited
- 31.5. Dong-A Pharmaceutical Co.
- 31.6. Ltd.
- 31.7. Aurobindo Pharma Ltd.
- 31.8. Alembic Pharmaceuticals Ltd.
- 31.9. Lupin Limited
- 31.10. Glenmark Pharmaceuticals Ltd.
- 31.11. Sun Pharmaceutical Industries Ltd.
- 31.12. AvKARE Inc.
- 31.13. Endo Pharmaceuticals Inc.
- 31.14. Teva Pharmaceutical USA
- 31.15. Aurobindo Pharma USA
32. Global Drugs For Erectile Dysfunction Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Drugs For Erectile Dysfunction Market
34. Recent Developments In The Drugs For Erectile Dysfunction Market
35. Drugs For Erectile Dysfunction Market High Potential Countries, Segments and Strategies
- 35.1 Drugs For Erectile Dysfunction Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Drugs For Erectile Dysfunction Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Drugs For Erectile Dysfunction Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
